Match tier
Listed
Presence
Current · Arkansas
Last published
2022
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
A
Amal Shoeib
Researcher
Also affiliated: Mansoura University (2015–2016); University of Arkansas Medical Center (2021)
Faculty Researcher
5 h-index
10 pubs
71 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Amal Shoeib's research focuses on the pharmacology of cannabinoid receptors and their potential as therapeutic targets, particularly in cancer treatment. Her work investigates the structure-activity relationships of novel compounds designed to selectively target cannabinoid receptors, such as CB1 and CB2. Shoeib has examined the expression and function of these receptors in various cancer cell lines, including Ewing sarcoma and prostate cancer cells, exploring their role in mediating cell death. Her recent publications detail the synthesis and molecular characterization of indole-based compounds as selective CB2 receptor antagonists and the identification of non-canonical cannabinoid receptors involved in cancer cell death. Shoeib has a h-index of 5, with 10 publications and 71 citations. She collaborates with several researchers at the University of Arkansas for Medical Sciences, including Paul L. Prather, Shengyu Mu, Alicja Urbaniak, and Azure L. Yarbrough.
Metrics
- h-index: 5
- Publications: 10
- Citations: 71
Selected Publications
-
Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death (2022)
-
Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development (2021)
-
Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors (2021)
-
Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists (2021)
-
7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands (2020)
-
Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity (2020)
-
Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22) (2019)
-
Quantitative microinjection using fluorescence calibration of streaming microdroplets on a superhydrophobic surface (2018)
Collaboration Network
Top Collaborators
Paul L. Prather
University of Arkansas for Medical Sciences
4 shared publications
In database
- Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lori L. Hensley
Jacksonville State University (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Benjamin M. Ford
University of Arkansas for Medical Sciences (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lirit N. Franks
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Alicja Urbaniak
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Azure L. Yarbrough
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Anna Radomińska‐Pandya
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lance Benson
University of Arkansas for Medical Sciences (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death
Shengyu Mu
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death
Harvey F. Fulo
West Virginia University (US)
1 shared publication
- Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists
Christian V. Cabanlong
University of Arkansas for Medical Sciences (US)
1 shared publication
- Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists
Alexander H. Williams
University of Kentucky (US)
1 shared publication
- Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists
Chang‐Guo Zhan
University of Kentucky (US)
1 shared publication
- Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists
Gregory B. Dudley
West Virginia University (US)
1 shared publication
- Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists
Karol Kacprzak
Adam Mickiewicz University in Poznań (PL)
1 shared publication
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Similar Researchers
Based on overlapping research topics
Azure L. Yarbrough
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Cancer Treatment and Pharmacology
Lirit N. Franks
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Cancer Treatment and Pharmacology
Hong-yu Li
University of Arkansas for Medical Sciences
Receptor Mechanisms and Signaling
Cancer Treatment and Pharmacology
Structure-Activity Relationship
Paul L. Prather
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Cancer Treatment and Pharmacology
Anna Radomińska‐Pandya
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Cancer Treatment and Pharmacology
J S James
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Pharmacological Effects and Toxicity Studies